Judicial approaches to tobacco control: The third wave of tobacco litigation as a tobacco control mechanism

Journal of Social Issues

Volumn 53, Issue 1, 1997, Pages 169-186

  Kelder Jr , Graham E ^a,b   Daynard, Richard A ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345280886     PISSN: 00224537     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-4560.1997.tb02437.x     Document Type: Article

References (43)

1. Barnes, D. E., Bero, L., Glantz, S.A., Hanauer, P., & Slade, J. (1995a). Lawyer control of internal scientific research to protect against products liability lawsuits: The Brown and Williamson documents, Journal of the American Medical Association, 274, 234-240.
2. Barnes, D. E., Bero, L., Glantz, S.A., Hanauer, P., & Slade, J. (1995b). Looking through a keyhole at the tobacco industry: The Brown & Williamson documents. Journal of the American Medical Association, 274, 219-258.
3. Complaint, Broin v. Philip Morris, 6.4 TOBACCO PRODS. LITIG. REP. 3.465 (1991).
4. Broin v. Philip Morris, 641 So.2d 888 (Fla. 1994).
5. First Amended Complaint, Castano v. American Tobacco, 9.2 TOBACCO PRODS. LITIG. REP. 3.49 (1994).
6. Castano v. American Tobacco, 10.1 TOBACCO PRODS. LITIG. REP. 2.1 (1995).
7. Castano v. American Tobacco, 11.3 TOBACCO PRODS. LITIG. REP. 2.99 (1996).
8. Cipollone v. Liggett Group, 112 S. Ct. 2608 (1992).
9. Cipollone v. Liggett Group, 893 F.2d 541 (3d Cir. 1990).
10. Cipollone v. Liggett Group, 789 F.2d 181 (3d Cir.1986).
11. Collins, J. & Hilts, P. J. (1995, June 8). Records show Philip Morris studied influence of nicotine. The New York Times, p. 1.
12. Daynard, R. A. (1994, November). The third wave of tobacco products liability cases, Trial, 30, 34-40.
13. Daynard, R. A. (1988). Tobacco litigation as a cancer control strategy. Journal of the National Cancer Institute, 80, 9.
14. Daynard, R. A. & Kelder, G. E. (1995, November). The tobacco industry under fire. Trial, 31, 20-25.
15. Edell, M., (1986, Fall) Cigarette litigation: The second wave. Tort & Insurance Law Journal, 22, 90.
16. Amended Complaint, Engle v. R. J. Reynolds, 9.3 TOBACCO PRODS. LITIG. REP. 3.293 (1994).
17. Federal Cigarette Advertising and Labeling Act, 15 U.S.C. §§ 1331-1341, (1994).
18. Freedman, A. (1996, January 26). The deposition: Cigarette defector says CEO lied to Congress about view of nicotine. The Wall Street Journal, p. A1.
19. Freedman, A. & Hwang, S. (1996, August 26). Legislation plan on tobacco advances. The Wall Street Journal, p. A2.
20. Gottlieb, M. (1994, May). Pandora's box of documents explodes. Tobacco On Trial, 1994 No. 4, p. 1.
21. Haines v. Liggett Group, 814 F. Supp. 414 (D.N.J. 1993).
22. Hwang, S., Geyelin, M., & Freedman, A. (1996, August 12). Jury's tobacco verdict suggests tough times ahead for the industry. The Wall Street Journal, p. A1.
23. Case Management Order, In re: Cigarette Cases, 11.1 TOBACCO PRODS. LITIG. REP. 2.3 (1996).
24. Kelder, G. (1995, March). Filing of florida lawsuit and ruling in Mississippi strip tobacco industry of its favorite legal defenses. Tobacco On Trial, 1995 No. 2, p. 1.
25. Kelder, G. (1996a, September). Hurricane season begins with a storm of suits by attorneys general. Tobacco On Trial, 6, p. 15.
26. Kelder, G. (1996b, January). Once more unto the breach. Tobacco On Trial, 1, p.1.
27. Kelder, G. (1996c, June). The sorcerer's apprentice. Tobacco On Trial, 4, p. 1.
28. Kessler, D. (1994, February 25). Letter to the Coalition on Smoking Or Health re: FDA regulation of cigarettes as drugs.
29. Levoy, J. (1996, January 27). Discount cigarette stores on the rise. Los Angeles Times, p. A1.
30. Levy, D. (1995, October 6). RJR memo targeted teen market. USA Today, p. 1D.
31. Complaint, Moore v. American Tobacco, 9.2 TOBACCO PRODS. LITIG. REP. 3.35 (1994).
32. Deposition of Jeffrey Wigand, Moore v. American Tobacco, 11.1 TOBACCO PRODS. LITIG. REP. 3.1 (1996).
33. U.S. Food and Drug Administration. (August, 1995). Nicotine in Cigarettes and Smokeless Tobacco Products is a Drug and These Products are Nicotine Delivery Devices Under the Food, Drug and Cosmetic Act, published at 60 Fed. Reg. 41, 454-41, 787 (Aug. 11, 1995).
34. Statement of Dr. William Farone, Nicotine in Cigarettes and Smokeless Tobacco Products is a Drug and These Products are Nicotine Delivery Devices Under the Food, Drug and Cosmetic Act, published at 11.2 TOBACCO PRODS. LITIG. REP. 8.13 (1996).
35. Statement of Jerome Rivers, Nicotine in Cigarettes and Smokeless Tobacco Products is a Drug and These Products are Nicotine Delivery Devices Under the Food, Drug and Cosmetic Act, published at 11.2 TOBACCO PRODS. LITIG. REP. 8.11 (1996).
36. Statement of Dr. Ian Uydess, Nicotine in Cigarettes and Smokeless Tobacco Products is a Drug and These Products are Nicotine Delivery Devices Under the Food, Drug and Cosmetic Act, published at 11.2 TOBACCO PRODS. LITIG. REP. 8.1 (1996).
37. Philip Morris v. CIR, 116 S. Ct. 1849 (1996).
38. Regulation of Nicotine-containing Products under the Federal Food, Drug and Cosmetic Act, 1994: Hearings Before the Subcomm. On Health & the Environment of the House Comm. on Energy & Commerce, 103d. Cong., 2d Sess. (1994) (opening statements of Henry Waxman and others).
39. Regulation of Nicotine-containing Tobacco Products under the Federal Food, Drug and Cosmetic Act, 1994: Hearings Before the Subcomm. on Health & the Environment of the House Comm. on Energy & Commerce, 103d Cong., 2d Sess. (statement of Dr. David Kessler, Commissioner, FDA).
40. R. J. Reynolds, v. Engle, 11.1 TOBACCO PRODS. LITIG. REP. 2.1 (1996).
41. Complaint, Scott v. American Tobacco, 11.4 TOBACCO PRODS. LITIG. REP. 3.514 (1996).
42. Shao, M. (1996, March 14). Tobacco firm agrees to settle suit; Move is called a milestone in cigarette wars. The Boston Globe, p. 1.
43. Smith v. R. J. Reynolds, 9.4 TOBACCO PRODS. LITIG. REP. 2.105 (1994).